Paradigm Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-5,700
| Closed | -$354K | – | 494 |
|
|
2017
Q2 | $354K | Sell |
5,700
-5,900
| -51% | -$366K | 0.07% | 284 |
|
|
2017
Q1 | $786K | Buy |
11,600
+10,000
| +625% | +$678K | 0.15% | 155 |
|
|
2016
Q4 | $112K | Hold |
1,600
| – | – | 0.02% | 381 |
|
|
2016
Q3 | $114K | Sell |
1,600
-150
| -9% | -$10.6K | 0.02% | 389 |
|
|
2016
Q2 | $85.6K | Sell |
1,750
-7,300
| -81% | -$357K | 0.01% | 487 |
|
|
2016
Q1 | $573K | Sell |
9,050
-400
| -4% | -$25.3K | 0.11% | 199 |
|
|
2015
Q4 | $1.06M | Buy |
9,450
+2,650
| +39% | +$297K | 0.18% | 111 |
|
|
2015
Q3 | $655K | Sell |
6,800
-34,100
| -83% | -$3.28M | 0.09% | 241 |
|
|
2015
Q2 | $4.19M | Hold |
40,900
| – | – | 0.47% | 78 |
|
|
2015
Q1 | $2.54M | Buy |
+40,900
| New | +$2.54M | 0.28% | 122 |
|